STAT3 and neoplasm: Tumor-derived factors from human and mouse cancers were shown to induce binding of STAT3 to negative regulatory elements in the promoter of PKCβII gene (PRKCB), strongly inhibiting its expression and decreasing expression of DC differentiation markers, such as CD11c, MHC class I and II complexes, and costimulatory molecules.